Nuclear Medicine Project

Nuclear Medicine Project

Describe one Nuclear Medicine diagnostic test. Radioactive iodine therapy or 1-131Radiopharmaceuticalradioiodine Diagnostic test Radioactive iodine or 1-131 is used to determine if one's thyroid is hyperactive, hypoactive or if cancerous cells are present.Medical conditionIt will determine if a person's thyroid is hyperactive or hypoactive based on a set of symptoms such as tiredness, weight gain or loss, constipation, muscle aches, depression or reduced concentration.Explain how the diagnostic test is utilized in the treatment.The test is used after it is determined what the functioning of the thyroid is and if the thyroid is hyperactive or hypoactive and to rule out cancer. Afterwards an ultrasound image is produced and or a CT (computed tomography) scan is used.Explain how the described radiopharmaceutical is benefical.The radioiodine is benefical in that it will allow the doctor to decide on the best course of treatment for the patient and prescribe the medication that is needed to help a person with a hyperactive, hypoactive or cancerous thyroid.Explain how the described radiopharmaceutical can be harmful. The radioiodine can be harmful with the following side effects: If too much radiation is given it can destroy the thyroid, fever, chills, nausea or vomiting, excessive fatigue, swelling or pain in the neck, tightness in the throat or trouble breathing, a rapid pulse, inability to urinate, dry eyes and dry mouth.Conclusions: The radioactive iodine therapy has proven to be an effective course of treatment in order to determine if a person has a hyperactive, hypoactive or cancerous thyroid